Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of popular, augmented reality, interactive, entertainment games and toys in China, is well positioned in a market that is anticipated to see continuous…
Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a biotechnology company and drug-delivery platform innovator, is increasing the reach of its revolutionary DehydraTECH(TM) technology that enables the rapid onset of ingested cannabis. An article discussing the company…
Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, this morning announced that it has received final approval to list its common shares on the Toronto…
Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments, this morning announced the entry of its wholly owned subsidiary, Khrysos Industries, Inc., into a 5-year supply contract with DJB…
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of popular, augmented-reality, interactive, entertainment games and toys in China, recently entered a strategic agreement with Guangdong Family Periodicals Group. The two companies…
The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, this morning announced the completion of its first shipment to the Ontario Cannabis Store. The shipment marks TGODF’s official entrance…
TransCanna Holdings (CSE: TCAN) (FSE: TH8) this morning announced a new appointment to its board of directors. Ian Klassen joins the board and will additionally serve as chair of the company’s audit committee. Klassen brings…
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) this morning announced the entry of its portfolio companies, James E. Wagner Cultivation Corporation (“JWC”) (TSXV: JWCA) (OTCQX: JWCAF) and TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF), into a purchase…
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced financial results for the second quarter ended…
Biotechnology company and global drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today announced the granting of four of its pending patent applications via its wholly-owned subsidiary Poviva Corp. According to the update,…
Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments, this morning reported financial results for the second quarter and six months ended June 30, 2019. Per the update, the…
Biotechnology company and global drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today announced the appointment of Brian Quigley to its board of directors. Quigley most recently spent 16 years at Altria Group,…
TransCanna Holdings (CSE: TCAN) (FSE: TH8) this morning announced its entry into a definitive purchase agreement for all of the outstanding equity interest in Tres Ojos Naturals LLC, doing business as SolDaze, a Santa Cruz,…
Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) on Tuesday released its financial and operational results for the three and six months ended June 30, 2019. In addition, TGODF…
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, on Tuesday announced that it will host a…
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) on Tuesday announced its plans to report first quarter fiscal year 2020 financial results before markets open on Tuesday, August 27, 2019. According to the update, Canopy Rivers will…
Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, has developed a unique, proprietary nano-emulsification technology that is anticipated to deliver an initial onset of effects…
Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) this morning announced its recent achievements as part of the company’s overall strategy to expand its clinical development programs and bring its lead drug candidate, Oncoprex(TM) immunogene therapy,…
Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) today announced that Health Canada has issued cannabis Research and Development (“R&D”) license LIC-7NONT76UNW-2019 to its subsidiary, Lexaria CanPharm ULC. According…
INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced its financial results for the second quarter ended June 30, 2019…